SEC Form 4 · accession 0001073397-18-000014

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

George A Lopez

Director · 10% Owner

Period of report

Jul 2, 2018

Accepted (ET)

Jul 3, 2018 · 6:53 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Jul 2, 2018	S	7,773	$290.78	D	387,875	D
Common Stock^F3	Jul 2, 2018	S	6,765	$291.54	D	381,110	D
Common Stock^F4	Jul 2, 2018	S	951	$292.56	D	380,159	D
Common Stock^F5	Jul 2, 2018	S	306	$293.47	D	379,853	D
Common Stock^F6	Jul 3, 2018	S	1,900	$289.48	D	377,953	D
Common Stock^F7	Jul 3, 2018	S	1,048	$290.41	D	376,905	D
Common Stock^F8	Jul 3, 2018	S	2,595	$291.61	D	374,310	D
Common Stock^F9	Jul 3, 2018	S	866	$292.24	D	373,444	D
Common Stock	holding	—	—		—	986,843	I	by Partnership

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
F2The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.05 to 291.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.10 to 292.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.15 to 293.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $293.35 to 293.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $288.95 to 289.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F7The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.00 to 290.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F8The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.05 to 292.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F9The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.08 to 292.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.